- Home
- MEDP vs COKE Comparison
MEDP vs COKE Comparison
Compare MEDP & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- COKE
- Stock Information
- Founded
- MEDP 1992
- COKE 1902
- Country
- MEDP United States
- COKE United States
- Employees
- MEDP N/A
- COKE N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- COKE Beverages (Production/Distribution)
- Sector
- MEDP Health Care
- COKE Consumer Staples
- Exchange
- MEDP Nasdaq
- COKE Nasdaq
- Market Cap
- MEDP 10.5B
- COKE 12.3B
- IPO Year
- MEDP 2016
- COKE N/A
- Fundamental
- Price
- MEDP $298.55
- COKE $1,369.02
- Analyst Decision
- MEDP Hold
- COKE
- Analyst Count
- MEDP 10
- COKE 0
- Target Price
- MEDP $343.22
- COKE N/A
- AVG Volume (30 Days)
- MEDP 763.4K
- COKE 50.4K
- Earning Date
- MEDP 04-21-2025
- COKE 05-05-2025
- Dividend Yield
- MEDP N/A
- COKE 0.73%
- EPS Growth
- MEDP 33.36
- COKE 60.86
- EPS
- MEDP 13.09
- COKE 69.94
- Revenue
- MEDP $2,156,580,000.00
- COKE $6,899,716,000.00
- Revenue This Year
- MEDP $4.03
- COKE N/A
- Revenue Next Year
- MEDP $9.30
- COKE N/A
- P/E Ratio
- MEDP $22.79
- COKE $19.88
- Revenue Growth
- MEDP 9.87
- COKE 3.69
- 52 Week Low
- MEDP $250.05
- COKE $819.72
- 52 Week High
- MEDP $459.77
- COKE $1,460.92
- Technical
- Relative Strength Index (RSI)
- MEDP 47.81
- COKE 50.73
- Support Level
- MEDP $250.05
- COKE $1,351.82
- Resistance Level
- MEDP $303.78
- COKE $1,421.32
- Average True Range (ATR)
- MEDP 18.07
- COKE 52.35
- MACD
- MEDP 1.50
- COKE 0.33
- Stochastic Oscillator
- MEDP 83.43
- COKE 68.92
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.